Cancer is a complex disease with numerous subtypes and varying responses to treatment among different populations. Global data collaboration allows for larger and more diverse datasets, which can lead to more robust and generalizable findings. This is particularly important for understanding rare cancers and identifying [biomarkers](href="") that may not be apparent in smaller, localized studies.
